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1. INTRODUCTION 2. METHODS 
There have been many reports of the action of 
morphine in reducing the release and the turnover 
of acetylcholine and biogenic amines both in vivo 
and in vitro [l--5]. Similarly enkephalins have been 
shown to inhibit the release of acetylcholine and 
biogenic amines from various in vivo and in vitro 
preparations 16-101. These effects are mostly pre- 
vented by naloxone. 
Release of amino acid neurotransmitters and 
acetylcholine from the motor cortex of awake, be- 
haviourally normal rats in vivo was suppressed by 
morphine given intraperitoneally, the effect being 
prevented by naloxone. This release was evoked 
either by low concentrations (1 PM) of the depolar- 
izing scorpion venom toxin, tityustoxin delivered 
onto the cortical surface [Ill, or by sensory stimu- 
lation of the motor cortex via the brachial plexus 
1121. 
Synaptosomes from rat cerebral cortex [ 141 were 
incubated at 37°C for 15 min in Ca2+-free 
Krebs-Tris medium of the following composition 
(mM): NaCI, 138; KCl, 5; MgS04,1.0; Tris, 20 (pH 
7.4); glucose, 10; before adding morphine sulphate 
at the levels indicated. After a further 15 min incu- 
bation, veratrine (a depolarizing alkaloid) was 
added as designated in table 1. Another 10 min 
incubation was allowed before 45Ca2+ (Amersham 
International) was added to give 1.2 mM final 
cont. and spec. act. 0.8 mCi/mmol. After 10 min the 
synaptosomes suspensions were added to ice-cold 
EGTA (final cont. 15 mM) and centrifuged 
immediately. The supernatants were stored for 
amino acid analysis whilst the pellets were taken for 
analysis of 45Ca2+ content (151. Amino acids were 
measured by autoanalysis as in [ 161. 
The implication is that the actions of morphine 
reflect the activities and function of a class of en- 
dogenous opioids, the enkephalins which serve to 
modulate neurotransmitter release possibly 
through an inhibitory action at presynaptic recep- 
tors. The inhibitory actions of enkephalins them- 
selves would support this proposal, though caution 
in interpreting the actions of enkephalin in vitro in 
terms of a physiological action in vivo have been 
firmly expressed [131 and some of the published 
findings have been re-appraised. 
Potassium was measured by flame photometry 
using an EEL (Evans Electra Selenium Ltd.) flame 
photometer. 
3. RESULTS AND DISCUSSION 
Here, the action of morphine on the control and 
veratrine or high K+-induced influx of 45Ca2+ to 
cerebrocortical synaptosomes in vitro, and its par- 
allel actions on amino acid neurotransmitter release 
have been investigated. 
The results in table 1 show that Ca2+ influx to the 
synaptosomes caused by the depolarizing action of 
veratrine is already maximal at 50 PM. The influx is 
blocked by tetrodotoxin (1 PM) indicating that the 
depolarizing action involves Na+-influx through 
active-Na+ channels. Amino acid release is maxi- 
mal at 75 FM and is similarly blocked by tetrodo- 
toxin. 
Morphine, even at 100 PM, was without effect on 
either 45Ca2+ influx or on amino acid efflux, 
evoked by 75 PM veratrine. However, it partially 
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Table 1 
Effect of morphine on 45Ca2+-influx and endogenous glutamate release 
Veratrine (PM) 75 50 25 K+ (40 mM) 














B: Glutamate release 
(nmol/ 100 mg protein) 
No. of samples 








(6) (4) (4) (2) 
3.66kO.13 3.64kO.09 3.71kO.08 
7.84-tO.10 8.35kO.30 5.7220.06 
3.7350.10 - 
a 8.16kO.31 8.3320.21 5.2620.18 
8.7620.35 6.58k0.24 5.1520.28 
8.84k0.37 6.4420.31 4.75kO.22 
8.41a0.29 6.1OkO.37 4.7250.23 
8.24kO.29 5.69kO.23 3.91k0.36 
(3) (3) (3) 
321 123 321 
2524 1745 1401 
2002 1612 613 
1887 1633 280 
1954 1489 320 
1891 1133 422 








a 4 Values (2 expt.) only for morphine added to 75 PM veratrine 
Data are mean or mean f SEM as appropriate for the numbers of samples 
indicated. Morphine alone (l-100 yM) had no effect on either 45Ca2+ influx or 
amino acid release in the absence of veratrine or high K+ 
blocked both of these responses to 50 PM veratrine 
(5-100 PM Ca*+ -influx; 15-100 PM, transmitter 
release). However, 45Ca2+ influx to the synapto- 
somes induced by 25 PM veratrine was completely 
blocked by 100 PM morphine but partially preven- 
ted by 1 PM. Influx due to high K+ (40 mM) was 
prevented by s 15 PM morphine (table 1). The 
depolarization induced release of amino acid neu- 
rotransmitters like 45Ca2+-influx was also inhibi- 
ted by morphine though the drug ‘showed a greater 
potency of action on neurotransmitter release. 
90 
Thus, for instance, the release evoked by 25 PM 
veratrine was completely blocked by morphine at 5 
yM. Table 1 shows data for glutamate only, but 
both aspartate and y-aminobutyrate showed ident- 
ical behaviour. These inhibitory actions of mor- 
phine were all prevented by naloxone at 1 PM (table 
2). 
Thus, both amino acid neurotransmitter release 
and 45Ca2+-influx to synaptosomes can be reduced 
or blocked by morphine over l-100 FM provided 
the depolarizing stimulus is not too great and this 
Volume 144, number 1 FEBS LETTERS 
Table 2 Table 3 
Effect of naloxone on morphine-inhibition of calcium 
fluxes and transmitter elease 
Effect of veratrine and morphine on K+-levels of 
synaptosomes 
Additions PM K+ content 
(p equiv./ 100 mg protein) 
Additions PM 45Ca2+ influx Glutamate release 














- 3.45 289 
25 5.12a 1407 
25 5.15a 280 
5 
25 5.65 1025 
5 
25 3.91a 325 
100 
25 5.75 1032 
100 
Data are mean of 3 or 4 (“) values. Naloxone was added 
10 min before addition of morphine. Other conditions are 
as for table 1 
effect is blocked by naloxone. The greater potency 
of action of mor hine on transmitter release com- 
pared with 45Ca P +-influx is presumably due to an 
exponential component in the mechanisms where- 
by Ca2+ initiates transmitter release, i.e., a small 
decrease in 45 Ca 2+ -influx would be reflected as a 
much larger decrease in transmitter release. Equally, 
only a fraction of the 45Ca2+ entering may be re- 
sponsible for transmitter release. 
Whether the concentrations of morphine em- 
ployed here are relevant to those reached in vivo, 
and form part of the primary mechanism of action 
of morphine (and, by implication of the enke- 
phalins) remains uncertain [13]. There is also the 
question of whether morphine acts by causing the 
blockage of both Ca2+ influx and transmitter release 
independently by an action on a third process. For 
instance, if morphine were to prevent depolariza- 
tion per se, the same 2 effects would be seen to occur 
simultaneously. This possibility was exam- 
ined. Measurement showed (table 3) that the sub- 
None 30.720.19 
Veratrine 25 19.0+0.06 
Veratrine 50 18.0&0.12 
Veratrine 50 18.7kO.46 
Morphine 1 
Veratrine 50 17.7kO.54 
Morphine 15 
Veratrine 50 18.OkO.39 
Morphine 100 
Veratrine 25 22.3 f 0.24 
Morphine 1 
Veratrine 25 19.8 + 0.26 
Morphine 15 
Veratrine 25 20.8 + 0.08 
Morphine 100 
Cortical synaptosomes were incubated at 37°C as in sec- 
tion 2. Values are mean 2 SEM for 4 values from 2 
synaptosome preparations 
stantial release of K+ to the incubation medium 
caused by veratrine was not prevented by morphine 
even at the highest levels used (100 PM). This sug- 
gests that veratrine did induce its usual degree of 
depolarization in the presence of morphine, and the 
latter’s primary action was rather to reduce or pre- 
vent Ca2+ influx, and thereby modulate neuro- 
transmitter release. A primary action of enke- 
phalins on the Ca2+ current associated with the 
action potential has been reported.[ 17,181. 
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